• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性核素心肌灌注显像分析中 Rb PET 测定的冠状动脉血流储备在疑似冠心病及正常心肌灌注患者中的预后价值。

Prognostic Value of Coronary Flow Capacity by Rb PET in Patients With Suspected Coronary Artery Disease and Normal Myocardial Perfusion at Semiquantitative Imaging Analysis.

机构信息

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy (E.Z., R.A., A.D., T.M., V.G., C.N., P.B., A.C., W.A.).

Department of Nuclear Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom (P.A.).

出版信息

Circ Cardiovasc Imaging. 2024 Nov;17(11):e016815. doi: 10.1161/CIRCIMAGING.124.016815. Epub 2024 Nov 7.

DOI:10.1161/CIRCIMAGING.124.016815
PMID:39508096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11575911/
Abstract

BACKGROUND

Coronary flow capacity (CFC) is a measure that integrates hyperemic myocardial blood flow and myocardial flow reserve to quantify the pathophysiological impact of coronary artery disease on vasodilator capacity. We assessed the prognostic value of CFC derived from Rb positron emission tomography/computed tomography in patients with suspected coronary artery disease and normal myocardial perfusion imaging.

METHODS

We studied 1967 patients with suspected coronary artery disease and normal myocardial perfusion at the semiquantitative analysis of stress/rest cardiac Rb positron emission tomography/computed tomography imaging. Coronary artery calcium scores were calculated and categorized into 3 groups: 0, 0.1 to 99.9, and ≥100. Patients were classified as having myocardial steal, severely reduced CFC, moderately reduced CFC, mildly reduced CFC, minimally reduced CFC, or normal flow using previously defined thresholds. The outcome end points were myocardial infarction and cardiac death, whichever occurred first.

RESULTS

During a mean time of 41±27 months, 49 events occurred (2.5% cumulative event rate, with an annualized event rate of 0.5% person-years). At multivariable Cox analysis, coronary artery calcium score categories and impaired CFC resulted as independent predictors of events (both <0.001). The annualized event rate was higher in patients with impaired CFC compared with those with normal CFC (<0.05). Kaplan-Meier analysis showed that patients with impaired CFC were at the highest risk of events.

CONCLUSIONS

In patients with suspected coronary artery disease and normal myocardial perfusion, impaired CFC is associated with a higher risk of cardiac events. Evaluating CFC can help identify patients' candidates for additional therapies to prevent future events.

摘要

背景

冠状动脉血流储备能力(CFC)是一种综合了充血性心肌血流和心肌血流储备能力的测量方法,用于量化冠状动脉疾病对血管扩张能力的病理生理影响。我们评估了 Rb 正电子发射断层扫描/计算机断层扫描得出的 CFC 在疑似冠状动脉疾病和正常心肌灌注成像患者中的预后价值。

方法

我们研究了 1967 例疑似冠状动脉疾病和应激/静息心脏 Rb 正电子发射断层扫描/计算机断层扫描成像半定量分析正常心肌灌注的患者。计算了冠状动脉钙评分,并分为 3 组:0、0.1 至 99.9 和≥100。使用先前定义的阈值,将患者分为存在心肌盗血、严重 CFC 降低、中度 CFC 降低、轻度 CFC 降低、轻度 CFC 降低或正常血流。终点是心肌梗死和心脏性死亡,无论哪种情况先发生。

结果

在平均 41±27 个月的时间内,发生了 49 例事件(累积事件发生率为 2.5%,年化事件发生率为 0.5%人年)。多变量 Cox 分析显示,冠状动脉钙评分类别和受损的 CFC 是事件的独立预测因素(均<0.001)。与 CFC 正常的患者相比,CFC 受损的患者年化事件发生率更高(<0.05)。Kaplan-Meier 分析显示,CFC 受损的患者发生事件的风险最高。

结论

在疑似冠状动脉疾病和正常心肌灌注的患者中,受损的 CFC 与更高的心脏事件风险相关。评估 CFC 可以帮助识别需要额外治疗以预防未来事件的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/54560ebc83db/hci-17-e016815-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/68c490d3045a/hci-17-e016815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/96ca0a52670c/hci-17-e016815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/e7de41bb6f3d/hci-17-e016815-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/1f60d70c2011/hci-17-e016815-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/54560ebc83db/hci-17-e016815-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/68c490d3045a/hci-17-e016815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/96ca0a52670c/hci-17-e016815-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/e7de41bb6f3d/hci-17-e016815-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/1f60d70c2011/hci-17-e016815-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9889/11575911/54560ebc83db/hci-17-e016815-g008.jpg

相似文献

1
Prognostic Value of Coronary Flow Capacity by Rb PET in Patients With Suspected Coronary Artery Disease and Normal Myocardial Perfusion at Semiquantitative Imaging Analysis.放射性核素心肌灌注显像分析中 Rb PET 测定的冠状动脉血流储备在疑似冠心病及正常心肌灌注患者中的预后价值。
Circ Cardiovasc Imaging. 2024 Nov;17(11):e016815. doi: 10.1161/CIRCIMAGING.124.016815. Epub 2024 Nov 7.
2
Prognostic Value of Modified Coronary Flow Capacity Derived From [O]HO Positron Emission Tomography Perfusion Imaging.改良的基于[O]HO 正电子发射断层扫描灌注成像的冠状动脉血流储备的预后价值。
Circ Cardiovasc Imaging. 2023 Sep;16(9):e014845. doi: 10.1161/CIRCIMAGING.122.014845. Epub 2023 Sep 19.
3
Prognostic value of modified coronary flow capacity by N-ammonia myocardial perfusion positron emission tomography in patients without obstructive coronary arteries.改良 N-氨甲酰基心肌灌注正电子发射断层扫描对无阻塞性冠状动脉疾病患者的预后价值。
J Cardiol. 2022 Feb;79(2):247-256. doi: 10.1016/j.jjcc.2021.09.001. Epub 2021 Sep 15.
4
Impact of Revascularization on Absolute Myocardial Blood Flow as Assessed by Serial [O]HO Positron Emission Tomography Imaging: A Comparison With Fractional Flow Reserve.连续[O]HO 正电子发射断层成像评估血运重建对绝对心肌血流的影响:与血流储备分数的比较。
Circ Cardiovasc Imaging. 2018 May;11(5):e007417. doi: 10.1161/CIRCIMAGING.117.007417.
5
Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease.冠状动脉 CT 血管造影联合选择性 PET 灌注成像对冠状动脉疾病的预后价值。
JACC Cardiovasc Imaging. 2017 Nov;10(11):1361-1370. doi: 10.1016/j.jcmg.2016.10.025. Epub 2017 May 17.
6
The impact of coronary revascularization on vessel-specific coronary flow capacity and long-term outcomes: a serial [15O]H2O positron emission tomography perfusion imaging study.冠状动脉血运重建对特定血管的冠状动脉血流储备能力和长期结局的影响:一项连续的 [15O]H2O 正电子发射断层扫描灌注成像研究。
Eur Heart J Cardiovasc Imaging. 2022 Jun 1;23(6):743-752. doi: 10.1093/ehjci/jeab263.
7
Routine Clinical Quantitative Rest Stress Myocardial Perfusion for Managing Coronary Artery Disease: Clinical Relevance of Test-Retest Variability.常规临床定量静息心肌灌注显像在冠心病管理中的应用:检测-复测变异性的临床相关性。
JACC Cardiovasc Imaging. 2017 May;10(5):565-577. doi: 10.1016/j.jcmg.2016.09.019. Epub 2016 Dec 21.
8
Quantitative relationship between coronary artery calcium and myocardial blood flow by hybrid rubidium-82 PET/CT imaging in patients with suspected coronary artery disease.疑似冠心病患者中通过混合铷-82正电子发射断层显像/计算机断层扫描成像评估冠状动脉钙化与心肌血流之间的定量关系
J Nucl Cardiol. 2017 Apr;24(2):494-501. doi: 10.1007/s12350-015-0359-1. Epub 2016 Jan 15.
9
Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging.锶-82 正电子发射断层成像心肌血流定量增加预后价值。
Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1203-10. doi: 10.1093/ehjci/jet068. Epub 2013 May 9.
10
Age- and Sex-Specific Myocardial Blood Flow Values in Patients Without Coronary Atherosclerosis on Rb-82 PET Myocardial Perfusion Imaging.在 Rb-82 PET 心肌灌注成像中,无冠状动脉粥样硬化患者的年龄和性别特异性心肌血流值。
Circ Cardiovasc Imaging. 2024 Jul;17(7):e016577. doi: 10.1161/CIRCIMAGING.124.016577. Epub 2024 Jul 16.

引用本文的文献

1
Prognostic value of myocardial flow reserve by PET imaging in patients with suspected coronary artery disease: A systematic review and meta-analysis.PET成像评估心肌血流储备在疑似冠心病患者中的预后价值:一项系统评价和荟萃分析。
Int J Cardiol Heart Vasc. 2025 Apr 10;58:101677. doi: 10.1016/j.ijcha.2025.101677. eCollection 2025 Jun.

本文引用的文献

1
Prognostic Value of Modified Coronary Flow Capacity Derived From [O]HO Positron Emission Tomography Perfusion Imaging.改良的基于[O]HO 正电子发射断层扫描灌注成像的冠状动脉血流储备的预后价值。
Circ Cardiovasc Imaging. 2023 Sep;16(9):e014845. doi: 10.1161/CIRCIMAGING.122.014845. Epub 2023 Sep 19.
2
Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.冠状动脉血流储备能力与血运重建后生存预测:生理基础与临床意义。
Eur Heart J. 2024 Jan 14;45(3):181-194. doi: 10.1093/eurheartj/ehad579.
3
Comparison of the prognostic value of impaired stress myocardial blood flow, myocardial flow reserve, and myocardial flow capacity on low-dose Rubidium-82 SiPM PET/CT.
低剂量 Rubidium-82 硅光电倍增管 PET/CT 下,压力负荷心肌血流、心肌血流储备和心肌血流容量的预后价值比较。
J Nucl Cardiol. 2023 Aug;30(4):1385-1395. doi: 10.1007/s12350-022-03155-6. Epub 2022 Dec 27.
4
Prognostic value of modified coronary flow capacity by N-ammonia myocardial perfusion positron emission tomography in patients without obstructive coronary arteries.改良 N-氨甲酰基心肌灌注正电子发射断层扫描对无阻塞性冠状动脉疾病患者的预后价值。
J Cardiol. 2022 Feb;79(2):247-256. doi: 10.1016/j.jjcc.2021.09.001. Epub 2021 Sep 15.
5
Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease.放射性核素 82 铷 PET/CT 显像评估冠状动脉功能障碍对伴明显冠状动脉疾病的耐药性高血压患者的预后价值。
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3162-3171. doi: 10.1007/s00259-021-05239-w. Epub 2021 Feb 16.
6
Mortality Prediction by Quantitative PET Perfusion Expressed as Coronary Flow Capacity With and Without Revascularization.定量 PET 灌注表示的冠状动脉血流能力与血运重建对死亡率的预测。
JACC Cardiovasc Imaging. 2021 May;14(5):1020-1034. doi: 10.1016/j.jcmg.2020.08.040. Epub 2020 Nov 18.
7
Combined evaluation of regional coronary artery calcium and myocardial perfusion by Rb PET/CT in predicting lesion-related outcome.Rb PET/CT 联合评估冠状动脉钙和心肌灌注在预测病变相关转归中的应用。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1698-1704. doi: 10.1007/s00259-019-04534-x. Epub 2019 Dec 14.
8
From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review.从亚临床动脉粥样硬化到斑块进展和急性冠脉事件:美国心脏病学会最新综述。
J Am Coll Cardiol. 2019 Sep 24;74(12):1608-1617. doi: 10.1016/j.jacc.2019.08.012.
9
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
10
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.冠状动脉微血管疾病的发病机制和治疗选择:美国心脏病学会最新综述。
J Am Coll Cardiol. 2018 Nov 27;72(21):2625-2641. doi: 10.1016/j.jacc.2018.09.042.